Evaluation of collaborative tuberculosis and human immunodeficiency virus activities in Phnom Penh, Cambodia

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 11, 2011, Pages 1535-1539

  Tsurugi, Yoko ^a,b   Eam, K K ^c   Eang, M T ^c   Uehara, R ^b   Nakamura, Y ^b   Murakami, K ^a   Sugiyama, T ^a   Yamada, N ^a   Ishikawa, N ^a  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c National Center for Tuberculosis and Leprosy Control (CENAT)   (Cambodia)

Author keywords

Cambodia; Human immunodeficiency virus; TB HIV; Tuberculosis

Indexed keywords

ADULT; AGED; ARTICLE; CAMBODIA; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE REGISTRY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; PATIENT MONITORING; PATIENT REFERRAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPUTUM SMEAR;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; CAMBODIA; CHILD; CHILD, PRESCHOOL; COINFECTION; COOPERATIVE BEHAVIOR; COUNSELING; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ORGANIZATIONAL OBJECTIVES; PATIENT CARE TEAM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROGRAM EVALUATION; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TUBERCULOSIS; YOUNG ADULT;

EID: 80053964117     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0455     Document Type: Article

References (30)

1. World Health Organization, Stop TB Partnership. Fight AIDS, fight TB, fight now: TB-HIV information pack. Geneva, Switzerland: WHO, 2004.
2. World Health Organization, Stop TB Department and Department of HIV/AIDS. Strategic framework to decrease the burden of TB/HIV. WHO/CDS/TB/2002.296. Geneva, Switzerland: WHO, 2002.
3. Godfrey-Faussett P, Maher D, Mukadi Y D, Nunn P, Perriëns J, Raviglione M. How human immunodeficiency virus voluntary testing can contribute to tuberculosis control. Bull World Health Organ 2002; 80: 939-945. (Pubitemid 36056085)
4. Laserson K F, Wells C D. Reaching the targets for tuberculosis control: the impact of HIV. Bull World Health Organ 2007; 85: 377-381. (Pubitemid 46718363)
5. Fujiwara P I, Clevenbergh P, Dlodlo R A. Management of adults living with HIV/AIDS in low-income, high-burden settings, with special reference to persons with tuberculosis. Int J Tuberc Lung Dis 2005; 9: 946-958. (Pubitemid 41549180)
6. Maher D, Harries A, Getahun H. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes: implications for policies. Trop Med Int Health 2005; 10: 734-742. (Pubitemid 41098140)
7. Harries A D, Boxshall M, Phiri S, et al. Providing HIV care for tuberculosis patients in sub-Saharan Africa. Int J Tuberc Lung Dis 2006; 10: 1306-1311. (Pubitemid 44924583)
8. Srikantiah P, Lin R, Walusimbi M, et al. Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and prevention. Int J Tuberc Lung Dis 2007; 11: 168-174. (Pubitemid 46219280)
9. Coetzee D, Hilderbrand K, Goemaere E, Matthys F, Boelaert M. Integrating tuberculosis and HIV care in the primary care setting in South Africa. Trop Med Int Health 2004; 9: A11-A15. (Pubitemid 38833344)
10. Kanara N, Cain K P, Laserson K F, et al. Using programme evaluation to improve the performance of a TB-HIV project in Banteay Meanchey, Cambodia. Int J Tuberc Lung Dis 2008; 12 (Suppl 1): S44-S50. (Pubitemid 351361918)
11. Ministry of Health, Kingdom of Cambodia. Report on national HIV seroprevalence survey amongst TB patients in Cambodia, 2005. Phnom Penh, Cambodia: Ministry of Health National Center for Tuberculosis and Leprosy Control, 2006.
12. Nonoyama M, Tsurugi Y, Shirai K, Ishikawa Y, Horiguchi M. Infl uences of sex-related information for STD prevention. J Adolesc Health 2005; 36: 442-445.
13. World Health Organization/Joint United Nations Programme on HIV/AIDS. Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva, Switzerland: WHO, 2007.
14. World Health Organization Western Pacifi c Region/US Centers for Disease Control and Prevention. A revised framework to address TB-HIV co-infection in the Western Pacifi c Region. Geneva, Switzerland: WHO, 2008.
15. Yi S, Poudel K C, Yasuoka J, Ichikawa M, Tan V, Jimba M. Influencing factors for seeking HIV voluntary counseling and testing among tuberculosis patients in Cambodia. AIDS Care 2009; 21: 529-534.
16. Thomas B E, Ramachandran R, Anitha S, Swaminathan S. Feasibility of routine HIV testing among TB patients through a voluntary counselling and testing centre. Int J Tuberc Lung Dis 2007; 11: 1296-1301.
17. Kanara N, Cain K P, Chhum V, Eng B, et al. Association between distance to HIV testing site and uptake of HIV testing for tuberculosis patients in Cambodia. Int J Tuberc Lung Dis 2009; 13: 226-231.
18. Mahendradhata Y, Ahmad R A, Lefèvre P, et al. Barriers for introducing HIV testing among tuberculosis patients in Jogjakarta, Indonesia: a qualitative study. BMC Public Health 2008; 8: 385.
19. World Health Organization. Co-management of HIV and active TB disease. In: Treatment of tuberculosis guidelines. 4th ed. Geneva, Switzerland: WHO, 2010: pp 69-71.
20. Blanc F, Sok T, Laureillard D, et al. Early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) signifi cantly enhance survival of severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis: results of the CAMELIA clinical trial. BMC Proceedings 2011; 5 (Suppl 1): O11.
21. Ministry of Health, National Centre for HIV/AIDS, Dermatology and STDs, Kingdom of Cambodia. Guidance on change in the biological criterion for starting antiretroviral therapy by increasing CD4 threshold from 250 cells per cubic milliliter to 350 cells per milliliter and antiretroviral therapy for TB-HIV patients. Phnom Penh, Cambodia: Ministry of Health, National Centre for HIV/AIDS, Dermatology and STDs, 2010.
22. Eang M T, Chheng P, Natpratan C, Kimerling M E. Lessons from TB-HIV integration in Cambodia. Bull World Health Organ 2007; 85: 382-383.
23. National Center for HIV/AIDS Dermatology and STD, National Center for Tuberculosis and Leprosy Control. Standard operating procedures (SOP) for implementing the three I's in continuum of care (CoC) settings. Phnom Penh, Cambodia: Ministry of Health, Kingdom of Cambodia, 2010.
24. Ministry of Health, Kingdom of Cambodia. Tuberculosis report 2007. Phnom Penh, Cambodia: Ministry of Health, National Center for Tuberculosis and Leprosy Control, 2008.
25. Varma J K, Nateniyom S, Akksilp S, et al. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study. BMC Infect Dis 2009; 9: 42.
26. Dean G L, Edwards S G, Ives N J, Matthews G, et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 2002; 16: 75-83. (Pubitemid 34062184)
27. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defi c Syndr 2006; 43: 42-46. (Pubitemid 44306486)
28. Whalen C, Horsburgh C R Jr, Hom D, Lahart C, Simberkoff M, Ellner J. Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis. AIDS 1997; 11: 455-460. (Pubitemid 27113006)
29. Dheda K, Lampe F C, Johnson M A, Lipman M C. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis 2004; 190: 1670-1676. (Pubitemid 39411018)
30. Zachariah R, Fitzgerald M, Massaquoi M, et al. Does antiretroviral treatment reduce case fatality among HIV-positive patients with tuberculosis in Malawi? Int J Tuberc Lung Dis 2007; 11: 848-853. (Pubitemid 47232261)